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Chapter 1
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Kathrin Herrmann
Freie Universität Berlin, Department of Veterinary Medicine, Institute of 
Pharmacology and Toxicology, Berlin, Germany; current address: Johns  
Hopkins University, Bloomberg School of Public Health,  
Baltimore, MD, United States
kherrma1@jhu.edu
1 Introduction
[R]efinement is never enough, and we should always seek further for
 reduction and if possible replacement.
russell and burch, 1959, Chapter 4
Russell and Burch introduced the principles of replacement, reduction, and 
refinement of animal experimentation in 1959 in their groundbreaking book, 
The Principles of Humane Experimental Technique, to eradicate inhumanity to-
wards non-human animals (hereinafter referred to as animals). They utilized 
the term inhumanity to indicate negative mental states experienced by animals 
used in research and the procedures that cause such mental states. Their goal 
was to avoid the use of animals wherever possible and to improve significantly 
the treatment of the animals still deemed indispensable, while improving the 
quality of scientific and medical research and testing (Russell and Burch, 1959). 
Since the 1990s, the 3Rs have slowly gained more acceptance within the animal 
research community. They have been recognized by organizations such as the 
Council of Europe (1986) and the World Organisation for Animal Health (2018), 
and they have been implemented in law in several countries, for example in 
Germany and in the UK (Herrmann, Köpernik and Biedermann, 2009; Zurlo, 
Rudacille and Goldberg, 1996).
Today, the principles are not only embedded in legislation in the  European 
Union (EU) but around the world (Bayne et al., 2015). In the EU, Directive 
2010/63/EU on the protection of animals used for scientific purposes came 
into effect in 2013, thereby requiring all EU Member States to implement the 
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3Rs fully. The EU Directive is more far- reaching compared to other legislation 
since it promotes a strong shift away from animal experimentation, with its 
goal being “full replacement of procedures on live animals for scientific and 
educational purposes as soon as it is scientifically possible” (European Parlia-
ment, 2010, Recital 10). Furthermore, the EU Directive mandates that replace-
ment should be the first priority, followed by reduction and then refinement 
to be implemented if animal use is deemed absolutely unavoidable (European 
Parliament, 2010, Recital 11). Russell and Burch (1959, Chapter 7) proposed the 
following hierarchy: “Suppose, for a particular purpose, we cannot use replac-
ing techniques. Suppose it is agreed that we shall be using every device of 
theory and practice to reduce to a minimum the number of animals we have 
to employ. It is at this point that refinement starts, and its object is simply to 
reduce to an absolute minimum the amount of distress imposed on those ani-
mals that are still used.”
As a result of the incorporation of the 3Rs into legislation, which has mainly 
been driven by ever-increasing societal concerns (cf. Clemence and Leaman, 
2016; European Citizens’ Initiative, 2016; Jones, 2017; Pew Research Center, 
2015, 2018), it would seem reasonable to expect changes within the research 
 industry, particularly replacement of animals with non-animal  models. How-
ever, the cumulative effect of any such replacements has not prevented the 
overall number of animals used from steadily increasing  since the 2000s (Euro-
pean Commission, 2013; Taylor et al., 2008; Taylor and Rego, 2016). When look-
ing at the 3Rs and their impact, it seems that refinement, the R of ultima ratio, 
is receiving the most attention by the laboratory animal science  community 
(AALAS, n.d.; FELASA., 2016), especially in basic and applied research where 
the majority of animals are utilized (in the EU, 65% of animals; cf. Daneshian 
et al., 2015). A survey conducted with participants of laboratory animal science 
training courses in four European countries found that refinement was seen as 
more feasible and more pressing than replacement and reduction of animal 
use (Franco, Sandøe and Olsson, 2018).
Due to this focus, the chapter starts by exploring the application of several 
refinement methods in practice, commencing with current housing and hus-
bandry standards and a discussion about the benefits of a “culture of care”, 
followed by assessing important experimental refinements. To further as-
sess the quality of animal-based research, it reviews necessary refinements 
in planning, conduct, and reporting practices of animal studies. The chap-
ter then moves on to look at feasible ways to reduce and replace animal use 
by, first discussing tools to appraise animal studies whose application could 
lead to a significant reduction of animal experiments and thus numbers of 
animals used. It subsequently reflects on what the scientific community has 
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been doing to move towards  replacement of animals in research, testing, and 
education. Finally, the chapter concludes with recommendations for steps to 
be taken to work towards using non-animal, human-relevant approaches to 
biomedical research and testing aimed to protecting human health.
2 Refinement of Animal Housing and Husbandry
Husbandry is a factor for contingent inhumanity in all types of experiment.
russell and burch, 1959, Chapter 4
Animals used in research, testing, and education spend their lives in a captive en-
vironment that is very different from their natural environment. Refined housing 
gives animals the opportunity to cope with some of the  stressors imposed by life 
in the laboratory (Mason, 2006). Improving their living conditions by trying to 
meet some of the animals’ basic behavioral needs is called environmental refine-
ment or environmental enrichment (EE). Krech, Rosenzweig and Bennett (1960) 
were the first to report biochemical changes in the brains of rats kept in a com-
plex housing environment and augmented with daily exposure to novel items in 
an open field. They coined the term EE when describing this paradigm (Benefiel, 
Dong and Greenough, 2005). Environmental Enrichment is defined as “[a]ny 
modification in the environment of captive animals that seeks to enhance the 
physical and psychological well-being of the animals by providing stimuli which 
meet the animals’ species-specific needs” (Baumans and van Loo, 2013). It  in-
cludes complex social and inanimate object stimulation (Rosenzweig, 1966). Its 
positive behavioral effects were first described in rats by Hebb in 1947, who 
kept them as companion animals in his home. He observed that the rats living 
in a more complex, stimulating environment learned better and more quickly 
(Hebb, 1947). In addition to enhancing cognition, EE also promotes neuronal 
activation, signaling and plasticity in a number of brain regions (Nithiananth-
arajah and Hannan, 2006). In the beginning, research on EE was conducted pri-
marily to assess changes in behavior and brain development. With the increased 
concern for animal welfare and the establishment of animal welfare science as a 
specific discipline, has EE been applied to improve the animals’ daily lives.
Aside from being driven by animal welfare and health concern, many ee-
related research projects have also assessed the influence of poor housing con-
ditions on research data. Garner (2005), van Praag, Kempermann and Gage 
(2000), and Würbel (2001, 2007), among others, demonstrated that life in bar-
ren cages leads to abnormal brain development and to physiological and be-
havioral  malfunction. Standard non- to little-enriched cages can cause a variety 
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of abnormal behaviors, such as stereotypies (abnormal repetitive behaviour 
patterns) (see e.g., Würbel and Stauffacher, 1994, 1996; Würbel, Stauffacher and 
Holst, 1996) and inactivity while awake, observed for example in rhesus mon-
keys ( Hennessy et al., 2014) and mice. Inactivity appears to be an alternative to 
stereotypic behavior and indicates a depression-like state (Fureix et al., 2016).
Nonetheless, for a period of time, a number of laboratory animal scientists 
strongly believed that standardizing the animals’ environment—by housing 
animals in barren cages—was essential to control environmental variables 
(e.g., Bayne, 2005; Eskola et al., 1999; Gärtner, 1999; Tsai et al., 2002, 2003, 2006). 
The assumption was that standardization was crucial to minimize both varia-
tion in the data and the risk of obtaining conflicting results in replicate stud-
ies. Many laboratory animal scientists were concerned that implementing EE 
would add undesirable variation to their responses to experimental treatments 
(e.g., Bayne, 2005; Eskola et al., 1999; Gärtner, 1999; Tsai et al., 2002, 2003, 2006). 
However, eight mouse strains kept under such uniform, standardized condi-
tions, and tested on highly standardized behavioral tests in different labora-
tories, showed significant laboratory dependent variations (Crabbe, Wahlsten 
and Dudek, 1999). Since then, studies by Augustsson et al. (2003), van de Weerd 
et al. (2002), Wolfer et al. (2004), and Würbel (2007) have demonstrated that 
housing conditions can be enriched without increasing variability in experi-
mental results. Additional experiments using mice confirmed earlier research 
findings that basic environmental enrichments (shelters and nesting mate-
rial) can be used without compromising the research data (André et al., 2018). 
Furthermore, this study showed that data from mice who had access to shel-
ters and nesting material is comparable to previous data collected under bar-
ren housing conditions, consistent with earlier findings (see Augustsson et al., 
2003). The authors concluded that the influence of enrichment on research 
outcomes was trivial, and that nesting material and shelters could be used with-
out negative impact on study outcomes or loss of comparability to previous 
data obtained from animals living in impoverished cages. (André et al., 2018). 
In the future, rather than using more animals in new experiments on this top-
ic, a systematic review (SR) could be undertaken to provide an overview of the 
accessible evidence and new knowledge without further animal use. It would 
also point out knowledge gaps and assess the quality and validity of the conduct-
ed animal studies (for more on SRs of animal experimentation, see e.g., System-
atic Review Center for Laboratory Animal Experimentation, syrcle, n.d. a).
This so-called standardization fallacy (Würbel, 2000), the belief that ho-
mogenization of study populations (using the same strain, age, sex, weight, 
housing conditions, etc.) is an essential part of good experimental design, ap-
pears to be one driver for the irreproducibility of results and for the lack of 
external validity (Bailoo, Reichlin and Würbel, 2014). External validity is the 
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extent to which experimental results can be used as a basis for generalizations 
to other human and non-human animal populations in other environmental 
conditions (van der Worp et al., 2010). This is why authors, including Richter, 
Garner and Würbel (2009), Richter et al. (2010), Würbel (2000), and Würbel and 
Garner (2007), promote systematic environmental heterogenization, which is 
a “controlled and systematic variation of the properties of any given animal (or 
animal population) and its environment within a single experiment” (Rich-
ter, 2017, p. 344). Voelk et al. (2018) compared 440 single- and multi-laboratory 
preclincial animal studies that had used the same overall number of animals. 
They compared effect size estimates and found that the studies conducted in 
one laboratory only, in most cases did not predict effect size correctly, where-
as multi-laboratory studies generated more consistent and accurate results. 
Within-study standardization was identified as a major cause of poor repro-
ducibility. Thus, Voelk et al. (2018) advocate for multi-laboratory design with 
no increase of overall number of animals being necessary to enhance repro-
ducibility and, potentially, external validity. 
EE combined with systematic heterogenization contributes to improved 
quality of animal experiments ( Richter,  Garner and  Würbel, 2009; Richter 
et al., 2010; Würbel, 2000; Würbel and Garner, 2007), whereas failure to provide 
animals with living conditions that meet their species-specific needs jeopar-
dizes both their welfare and experimental validity (e.g., Bailey, 2018; Balcombe, 
2010; Bayne and Würbel, 2014;  Garner, 2005; Messmer et al., 2014; Olsson et al., 
2003; Poole, 1997; Sherwin, 2004; Würbel, 2001, 2007; Würbel and Garner, 2007).
2.1 Examples of Environmental Refinement
An example of an extensively researched refinement method is providing mice 
with various types and sufficient amounts of nesting material to build nests, 
creating a microclimate needed for breeding and for preventing cold stress 
(Gaskill et al., 2009, 2012; Gaskill and Garner, 2014; Hess et al., 2008). The ther-
moneutral zone of mice lies between 26°C and 34°C (Gordon, 1993); and stan-
dard temperatures in animal vivariums range between 20°C and 24°C. During 
their inactive phase, mice prefer temperatures of 30°C–32°C (Gordon, 2012). 
A proper nest is, therefore, essential for reducing cold stress, which not only 
compromises animal well-being but also scientific data (Gaskill et al., 2009; 
Karp, 2012; Messmer et al., 2014). Gaskill et al. (2013) additionally demonstrate 
its negative effect on breeding performance. Nest building is a species-specific 
behavior of mice, the absence of which can be used as an indicator of illness 
(Gaskill and Pritchett-Corning, 2016). Another example involves gerbils, who 
have a high motivation to dig, since they naturally build and live in burrows. 
In standard laboratory conditions, where there is not enough substrate to dig 
tunnels, gerbils show stereotypic digging behavior (Wiedenmayer, 1997). One 
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solution, based on research conducted by Waiblinger and König (2004), is a 
nesting box with an attached tunnel. The artificial burrow system seems to 
help reduce stereotypic digging behavior.
Jirkhof (2015) found that housing conditions that meet the needs of mice 
help them recover better and faster from experimental procedures. The influ-
ence of environment on diseases, such as cancer, has also been demonstrated; 
for example, by Cao et al. (2010). In colon cancer and melanoma research, 
mice living in an enriched environment showed reduced tumor growth and 
increased remission compared to those living in a non-enriched environment 
(Cao et al., 2010). Rabbits who received special positive attention from their 
care givers showed a markedly increased resistance to the development of 
atherosclerosis compared to rabbits who received no extra attention (Nerem, 
Levensque and Cornhill, 1980).
2.2 Discussion on Environmental Refinement
It has been established that animals in a monotonous environment fre-
quently display abnormal behaviors, such as stereotypies (Garner, 2005; Gar-
ner and Mason, 2002; Gross et al., 2012; Howerton, Garner and Mench, 2008; 
Würbel and Stauffacher, 1994, 1996; Würbel, Stauffacher and Holst, 1996). 
Furthermore, research has demonstrated the importance of environmen-
tal refinement, not only for animal welfare and for decreasing the negative 
health effects of life in captivity, but for its benefits for research outcomes 
in terms of their reliability, replicability, and validity (e.g., Abou-Ismail and 
Mahboub, 2011; Garner, 2005; Weed and Raber, 2005).
Due, at least in part, to enforcement of animal protection laws, housing 
conditions for laboratory animals have improved over the past decade. In the 
EU, the Commission Recommendation of 18 June 2007 on guidelines for the 
accommodation and care of animals used for experimental and other scien-
tific purposes (Commission of the European Communities, 2007)—which was 
later largely adopted by Directive 2010/63/EU (European Parliament, 2010, 
Annex iii)—helped to enhance the captive environment of laboratory ani-
mals. However, exceptions to these minimum requirements may be demanded 
by researchers for certain experiments. Examples include housing social spe-
cies, such as rats, pigs, or non- human primates, individually and away from 
their social groups; or not  providing rodents with sufficient nesting material 
and shelters, to allow easier and quicker monitoring. Yet, in most cases, a solu-
tion that considers the animals’ well-being and does not further compromise 
their welfare could probably be found.
Moreover, it should be noted that the term most frequently used when talk-
ing about an improved living environment, environmental enrichment, can 
be misleading, since it suggests that the standard cage conditions should be 
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considered normal or species-typical. However, captive conditions have little in 
common with the natural habitat of every single species used in research. For 
example, Lahvis (2017) points out that the floor area in a standard mouse cage 
is 280,000-times smaller than the animal’s natural home range. For rhesus ma-
caques, he calculated it is 7 million-fold smaller. Along with the difference in the 
size of the animals’ habitats, the stimulation provided in laboratories is also dif-
ferent from what animals encounter in their natural environments. Burghardt 
(1996) argues that it would be more accurate to use the term controlled depriva-
tion, since all captive environments deprive animals of some natural stimuli. 
He points out that these restrictions have various, and oftentimes unpredict-
able, consequences for the welfare of captive animals (Burghardt, 1996, 1999). 
In fact, a study by Gross et al. (2012) showed that around 12% of mice who lived 
in enriched cages which contained nesting material, a shelter and a climbing 
structure, still revealed stereotypic behavior. Moreover, evidence indicates that 
when stereotypies are not observed, a potential reason could be that they are 
only displayed when nobody is watching, e.g., in the nocturnal phase (Wells, 
2017); or, since highly stereotypic animals seem to cope better than their 
identically-treated conspecifics, non-stereotypic animals present an even 
more abnormal, depression-like state as an alternative to stereotypic behavior 
(Mason, 2006). It has been shown that sustained, uncontrolled stress can, at 
least in some mouse strains, foster learned  helplessness (Cabib, 2006).
2.3 Challenges in the Implementation of Refined Housing
The enforcement of animal protection laws has contributed to somewhat 
improved housing conditions for laboratory animals over the past decade. 
However, despite the mounting evidence of welfare and scientific problems 
 associated with standardized housing, the implementation of animal hus-
bandry knowledge in laboratories has in the author’s experience been a major 
and elusive challenge.
It is increasingly recognized that experimental animals experience serious 
and repeated stress and distress, caused by life in the laboratory. Besides being 
a welfare concern, there are multiple factors that adversely affect the animal’s 
biological systems and thus the data collected from these animals (Bailey, 
2018). Examples for stressors and thus potential influences on data, besides 
the confinement itself, include  ultrasonic noises (Baldwin, Primeau and John-
son, 2006; Turner et al., 2005), bedding material and cage cleaning (Burn et al., 
2006), handling, blood collection, and orogastric gavage (Balcombe, Barnard 
and Sandusky, 2004), and the experimenters (Chesler et al., 2002) and their sex 
(Baldwin, Primeau and Johnson, 2006; Sorge et al., 2014).
Numerous studies have shown that animals living in captive environments 
are generally abnormal and unhealthy, as such environments change their 
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behavior as well as immune, nervous, and endocrine functionality. Examples 
include their altered response to infection (Gurfein et al., 2014), altered immune 
response (Beura et al., 2016; Messmer et al., 2014), increased rates of obesity, 
Type ii diabetes, high blood pressure, and premature death (Martin et al., 2010), 
altered brain development (Bennett et al., 1964; Kempermann, Kuhn and Gage, 
1997; Lewis et al., 2006; Rosenzweig and Bennett, 1969; Rosenzweig et al., 1962), 
decreased strength and endurance (During et al., 2015), altered sleep, activity 
patterns, and blood pressure (Martire et al., 2012), altered growth rates (Serrat, 
King and  Lovejoy, 2008), altered organ development, metabolic, growth, and 
reproduction rates and behavior (Gordon, 2012), and enhanced tumor growth 
(Cao et al., 2010; Li et al., 2015). As such, untreated control animals do not repre-
sent healthy individuals, since they are metabolically abnormal (Martin et al., 
2010). To date, there are only a few studies comparing wild versus confined ani-
mals, but they all show immense biological differences in physiology, such as 
structure variation of the visual cortex among caged and free-roaming Norway 
rats (Campi et al., 2011), lower levels of cholesterol in wild versus captive animals 
(Schmidt et al., 2006), and immune system dissimilarities (Beura et al., 2016).
We must acknowledge that even if laboratory animal housing is enriched, it 
cannot be enriched to an extent that it has no negative effect on the animal’s 
welfare (e.g., Burghardt, 1996; Gross et al., 2012). Well-being can only be achieved 
if the animal experiences positive welfare states, which require a responsive en-
vironment the animal can engage with. Studies show that animals prefer com-
plex environments and are motivated to work for them (Anselme, Robinson 
and Berridge, 2013; Sherwin et al., 2004). Current minimum legal requirements 
for animal housing in the European Union, laid out in Directive 2010/63/EU, 
are still insufficient in meeting all needs of all animals; although they are held 
to be the most progressive in the world. As shown, problems of confinement 
are manifold. Animals’ lives in captivity are monotonous and, therefore, lead 
to boredom (Burn, 2017; Meagher and Mason, 2012), learned helplessness and 
depression (Cabib, 2006; Špinka and Wemelsfelder, 2011), and abnormal behav-
iors. The effects pose serious welfare concerns and raise concerns about the 
validity and translatability of data obtained from these unhealthy individuals.
2.4 Potential Improvements
In assuming an ethical responsibility to improve the lives of captive animals 
(Gruen, 2014), the goal of husbandry refinement should be not only to reduce 
stressors but to promote well-being. It is apparent that current housing con-
ditions do not achieve that. One step towards improving animal housing is 
to provide cages that allow for more natural behaviors. Makowska and Weary 
(2016a) investigated the frequency of burrowing, climbing, and standing 
11Refinement on the Way Towards Replacement
<UN>
upright of rats held in pairs in standard (behaviorally restrictive) laboratory 
cages in comparison with rats in cages allowing these behaviors (larger cages 
with lower floors, filled with moist soil, holding five rats per cage) over a period 
of 13 months. Although climbing bouts decreased with age, standing upright 
and especially burrowing were still frequent behaviors in older rats. Stretching 
is a corrective response to stiffness caused by immobility or positional stress 
(Bertolucci, 2011). Makowska and Weary (2016a) found that standard-housed 
rats performed 9 times more lateral stretches than rats housed in the semi-
naturalistic environment. The authors proposed that standard-housed rats 
were stretching frequently in an attempt to alleviate stiffness from low mobil-
ity associated with standard housing. Improved welfare of the rats housed in 
the semi-naturalistic cages was observed in an anticipatory behavior test that 
assessed differences in reward sensitivity performed when the rats were 19 and 
21 months old (Makowska and Weary, 2016b).
From the animals’ perspective, an even better approach would be the radi-
cal solution for housing refinement proposed by Lahvis (2017). Lahvis suggests 
that research animals should live in the wild or at least roam freely in a large, 
captive environment under naturalistic conditions. He is confident that with 
available technologies (e.g., cameras, transponders, magnetometers, pressure 
sensors, global positioning systems), this novel approach could be accom-
plished for many experiments. Lahvis (2017) advises that biomedical research-
ers should work together with behavioral ecologists to develop sufficiently 
complex environments in order to ensure that test subjects produce scientific 
data not influenced by husbandry.
3 A “Culture of Care” for Animals as Refinement
The term culture of care has frequently been referred to by members of the 
laboratory animal science community to demonstrate “a commitment to 
improving animal welfare, scientific quality, care of the staff and transpar-
ency for the stakeholders.” (Norecopa, 2016a). For instance, a working docu-
ment on the development of a common education and training framework 
to fulfill Directive 2010/63/EU requirements mentions the culture of care 
numerous times (National Competent Authorities for the implementation 
of Directive 2010/63/EU on the protection of animals used for scientific pur-
poses, 2014). Individuals responsible for the welfare of animals should estab-
lish and maintain high standards to champion a culture of care among both 
husbandry and scientific staff (European Commission, 2014). Entire sessions 
at conferences have been dedicated to this topic, including sessions at the 
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European Society for Alternatives to Animal Testing (eusaat) Congress in 
2015 (eusaat, 2015) and at the 10th European World Congress on Alternatives 
and Animal Use in the Life Sciences in Seattle in 2017 (von Aulock, 2017).
Reinhardt (2003, p. 123) identifies compassion for laboratory animals as a 
refinement: “Kindness and concern for animals in the laboratory often have 
been stigmatized as subjective, emotional qualities that can undermine the 
‘objectivity’ of biomedical and psychological research.” However, since there 
is evidence that the human-animal bond helps animals to cope with stressful 
situations in the laboratory (Wolfle, 1987), compassion for laboratory animals 
should not be dismissed as emotional and subjective but as a sound meth-
odological base for scientifically valid animal-based research (see Mahoney, 
1992; Reinhardt, 2003). Compassion implies an acute awareness of an animal’s 
state of emotional, behavioral, and physical well-being and the urge to provide 
them with the conditions essential for optimal well-being (Reinhardt, 2003). 
 According to Herzog, “there is every reason to believe that individuals who 
care about their wards on a personal level actually treat the animals better.” 
(2002, p. 30). Morton highlights that, ideally, the staff assessing pain in ani-
mals should have an empathetic attitude toward them (Morton, 2000). Such 
a mindset can also be seen as a protection mechanism to control unrelated, 
potentially data-influencing, variables (Reinhardt, 2003). Brown (2014) states, 
“Although there are laws and regulations that govern working with research 
animals, institutions involved in research, testing, and teaching using labora-
tory animals should strive to go beyond what is legally required and work to 
establish a ‘culture of care’ to ensure animals are treated with compassion and 
respect.” Brown highlights that this culture of care for animals not only ben-
efits animals but the quality of science as well.
3.1 From Theory to Practice
How far a culture of care is being implemented on an institutional level is 
unknown. Personal experiences of this author—as an inspector of animal 
 research institutions in Germany between 2007 and 2016 (Herrmann, 2013; 
Herrmann and Ratsch, 2010; Maurin, 2012)—revealed differences regarding 
the level of care for animals within the same institutions, with individual care 
givers acting more or less compassionately towards their animals. An institu-
tional culture of care agenda could not be identified.
The European Commission (EC) (2014) recommends the implementa-
tion of such a culture, and other countries have taken steps, in this direction. 
For example, New Zealand’s National Animal Ethics Advisory Committee 
guide is called A Culture of Care: A Guide for People Working with Animals 
in Research, Testing, and Teaching (National Animal Ethics Advisory Com-
mittee, 2002). Several  pharmaceutical companies, such as Sanofi-Aventis 
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and Merck (Klein and Bayne, 2007), and commercial breeding companies 
(Brown, 2014) are reported to have established culture of care programs; how-
ever, no external review or assessment of these programs has been published.
3.2 Towards a Culture of Care and Compassion for Animals
There is potential for a positive impact of a culture of care on animal use and 
welfare. But how can we implement such a culture? Schuppli et al. (2017) used 
a new educational approach to test if exposure to socialized rats, who were 
trained to fulfill several tasks, fostered compassion among animal experiment-
ers. Six rats were trained using positive reinforcement techniques to, for ex-
ample, jump onto a scale, or to lift objects. Participants observed these rats 
and engaged with handling them. After the class, researchers (17) discussed 
their feelings and reactions. Main findings included that all participants were 
impressed by the rats’ abilities and the close relationship with their trainers. 
They assumed that this positive animal-human interaction decreased stress in 
the rats. However, various views existed in regard to potential effects on data. 
The experimenters expressed unease about emotional difficulties in “sacri-
ficing” their experimental animals after having bonded with them (Schuppli 
et al., 2017). This highlights one of the major obstacles: When animal 
 researchers develop compassion for their research subjects, they face moral 
difficulties (see Birke, Arluke and Michael, 2007; Gluck, 2016) and moral harms 
(see  Chapter 13 in this Volume, Johnson and Smajdor, 2019) just as animal care-
takers and technicians do. However, this could be an important starting point 
in moving towards a culture of compassion for all animals which could con-
tribute to their replacement efforts. 
4 Refinement of Experimental Procedures
There are several essential refinement methods to reduce the pain, distress, 
anxiety, and suffering inflicted during the course of experimenting on the ani-
mals. Handling and restraint techniques are a source of potential distress and 
anxiety (Balcombe, Barnard and Sandusky, 2004; Hurst and West, 2010; 
Meijer et al., 2006); and these techniques have been investigated in experimen-
tal studies on stress (Johnson, Sharp and Miller, 2000). To avoid negative ef-
fects on behavior, tail handling of mice should be replaced by using tunnels 
or cupping mice in the open hand (Gouveia and Hurst, 2013). These and other 
 non-aversive handling practices should be implemented industry-wide, since 
they have been shown to reduce anxiety (Hurst and West, 2010) and optimize 
the performance of mice in behavioral tests (Gouveia and Hurst, 2017). A  recent 
study by Clarkson et al. (2018) concluded that particular handling methods can 
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not only cause anxiety, but they can also alter the hedonic value of reward. 
Tail-handled mice demonstrated a decreased responsiveness to reward and, 
potentially, a more depressive-like state compared to tunnel handled conspe-
cifics (Clarkson et al., 2018).
For surgical procedures, basic experimental refinements include: proper 
acclimatization of the animals to the room where anesthesia will be induced 
(Flecknell, 2018a); optimal anesthesia, peri- and postoperative analgesia; and 
adequate postoperative monitoring and care, including pain management 
(Flecknell, 2016; Herrmann and Flecknell, 2018a). The application of humane 
endpoints also prevents needless suffering. A humane endpoint (or “less- 
inhumane endpoint,” see Balls, 1999, p. 1) represents “[t]he earliest  indicator in 
an animal experiment of (potential) pain and/or distress that, within its scien- 
tific context and moral acceptability, can be used to avoid or limit adverse 
 effects by taking actions, such as humane killing, terminating the study, or al-
leviating the pain and distress.” (Hendriksen, Morton and Cussler, 2011, p. 344). 
The way an animal is killed is another subject for refinement. Animal care 
policies in many countries stipulate that death must be painless, and fear and 
anxiety should be minimized (e.g., Charbonneau et al., 2010; European Parlia-
ment, 2010). Less inhumane killing comprises the use of the least distressing 
and least painful methods that cause rapid loss of consciousness and subse-
quent death (see e.g., Leary et al., 2013).
The application of our steadily increasing knowledge on experimental re-
finements should benefit the over 115 million animals who are used annually in 
research, testing, and education around the world (Knight, 2008; Taylor et al., 
2008). However, this benefit cannot be achieved unless the knowledge is trans-
lated into practice. In cases where research workers plan to use, for example, 
less than optimal anesthesia or analgesia protocols, or do not provide other 
standard veterinary practices, they need to scientifically justify this and dem-
onstrate that the anticipated benefits of the experiments still outweigh the 
harms inflicted upon the animals (Herrmann and Flecknell, 2018b). Due to the 
multitude of available means, solutions can be found, in most cases, that help 
prevent needless animal suffering (Herrmann and Flecknell, 2018a).
4.1 The Use of Experimental Refinements in Practice
Several structured and systematic literature reviews have given some insight 
on certain experimental refinements, notably, killing methods (Pound and 
Nicol, 2018; Uhlig et al., 2015) and the use of anesthetics and analgesics (Ber-
trand, Sandersen and Flecknell, 2018; Carbone and Austin, 2016; Coulter, Fleck-
nell and Richardson 2009; Coulter et al., 2011; Pound and Nicol, 2018; Richardson, 
and Flecknell, 2005; Stokes, Flecknell and Richardson, 2009; Uhlig et al., 2015). 
For example, animal research involving surgical procedures carried out on 
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diverse species and published in peer-reviewed journals has been analyzed 
with regard to analgesic and anesthetic administration (Coulter et al., 2011; 
Coulter, Flecknell and Richardson, 2009; Richardson and Flecknell, 2005). 
Stokes, Flecknell and Richardson (2009) focused on studies conducted in two 
time periods (2000–2001 and 2005–2006), assessing trends in the administra-
tion of analgesics and anesthetics to laboratory mice and rats undergoing sur-
gical procedures. The study showed a trend of improvement in terms of safer 
anesthetic regimens used in the later period examined; however, the findings 
of this study and an earlier review assessing analgesic use in rodents (Richard-
son and Flecknell, 2005) show that there was still significant scope for refine-
ment, especially with respect to perioperative care.
A systematic review of anesthesia, analgesia and euthanasia methods used 
in anesthesiology, respiratory and critical care research in top-10 impact fac-
tor ranked journals journals pointed to insufficient reporting of experimental 
studies with small laboratory mammals. Despite the poor reporting, the review 
found shortcomings in the application of refinement (Uhlig et al., 2015). An-
other recent attempt to assess trends in pain management, this time in papers 
published before 2011 and from 2014 to 2015, further confirmed that reporting 
(and probably the use) of experimental refinement methods is still poor (Car-
bone and Austin, 2016). The review demonstrated that scientific publications 
still cannot be relied upon to present a detailed description of analgesia and 
anesthesia protocols, not to mention other experimental refinements.
Another approach employed by the author of this chapter, with Flecknell 
(2018 a, b, c), was to retrospectively review proposals for authorization of basic 
and applied animal research studies to learn which experimental refinements 
were proposed. Over 500 applications submitted to the German competent 
authorities in 2010 were reviewed. German law stipulates that all possible re-
finements that are planned in an animal study are described in detail in its pro-
posal. The review’s goal was to evaluate the intended application of and, thus, 
the awareness about possible refinements. Among other results, postoperative 
analgesia was not proposed for 30% of surgeries; and, in the majority of cases, 
its scientific necessity was not further discussed. Following 10% of procedures, 
animals were to be given pain relieving medication only if the investigators 
decided that it was necessary; however, structured assessments to detect pain 
were absent (Herrmann and Flecknell, 2018a).
4.2 Discussion on Refinement of Experimental Procedures
Structured and systematic literature reviews and the work of this author found 
strong indications for flaws in the administration of experimental refinement. 
Refinement methods need to be fully employed in order to minimize stressors 
that can lead to distress, such as suffering from postoperative pain, or living 
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in a barren cage. The biological consequences of stress and distress compro-
mise rigor, reliability, and relevance of data collected from these animals (see 
Bailey, 2018 for a review on how stress of laboratory life and experimentation 
can adversely affect research data). Animal researchers are responsible for the 
animals they use (National Health and Medical Research Council, 2013). Thus, 
they and their animal care staff should know enough about animal behavior 
to properly assess the health and well-being of their test subjects. In the Eu-
ropean Union, they are legally required to be skilled, educated, and equipped 
to detect and relieve suffering accordingly (European Parliament, 2010, 
Article 24).
There are several challenging areas of refined care and use that should be 
 addressed. For example, there is a need for automated, remote, 24/7 cage-side 
monitoring to identify abnormal behavior, which is especially important when 
 assessing the welfare of genetically modified animals, as well as for prey spe-
cies who tend to mask their medical condition or psychological state. Addi-
tionally, there is a need for further development and implementation of valid 
pain-assessment techniques to determine the efficacy of treatment in the in-
dividual animal due to individual variations in pain response. While there is 
necessity for further research into certain areas of experimental refinement, it 
is essential that we apply the knowledge we already have, so that immediate 
improvements in animal welfare can be achieved.
5 Refinement of Experimental Design, Conduct, and Reporting
There have been quality problems throughout medical and biomedical re-
search (Begley and Ellis, 2012; Harris, 2017; Pound and Bracken, 2014; Prinz, 
Schlange and Asadullah, 2011). “The scandal of poor medical research” with hu-
man subjects was discussed in a British Medical Journal (bmj) editorial in 1994 
( Altman, 1994). A biostatistician took a prominent stance against the unethical 
misuse of statistics (Altman, 1980). In a follow up 20 years later,  another bmj ed-
itorial called, “Medical research—still a scandal,” concluded that matters have 
become worse (Smith, 2014). It is apparent that the quality of in vivo research 
with animal and human subject demands urgent improvement. Weaknesses in 
design, conduct, and analysis of biomedical and public health research studies 
yield misleading results and, thus, waste resources (Ioannidis et al., 2014). Since 
legally-required animal data forms the basis of decisions to move forward to 
human clinical trials, flawed animal research is additionally problematic.
Aside from evidence that many animal experiments that are performed 
never get published (Scherer et al., 2018), a large part of what gets published is 
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incorrect (e.g., Harris, 2017; Ioannidis, 2005; Freedman, Cockburn and Simcoe, 
2015). Ioannidis (2005) argues that it is highly probable that most published 
findings are indeed false. He drew his conclusion after conducting simulation 
studies and SRs. He calculated that, at best, only one in three publications took 
basic precautions to minimize bias (Ioannidis, 2005). Freedman, Cockburn 
and Simcoe (2015) estimated that more than 50% of all preclinical studies in 
the United States are unreliable, and that the financial damage of these irre-
producible preclinical studies is US$28 billion per year. Their analysis  revealed 
that about 20% of the studies had an untrustworthy experimental design, one 
quarter used media that contained contaminated cells and antibodies, and 
in 18% of studies the data analysis was poor. All of these issues have contrib-
uted to the so-called reproducibility crisis in animal research (e.g., Aarts et al., 
2015; Baker, 2016; Begley and Ioannidis, 2015; Bracken, 2009; Collins and Tabak, 
2014; Freedman, Cockbury and Simcoe, 2015; Ioannidis, 2005; Perel et al., 2007; 
Pound et al., 2004; Pound and Bracken, 2014; Reichlin, Vogt and Würbel, 2016; 
Scannel and Bosley, 2016; Würbel, 2016). A review of the literature by Bailoo, 
Reichlin and Würbel (2014) strongly suggests that experimental design and 
conduct of laboratory animal research are in need of improvement. A study 
by Vogt et al. (2016) revealed that animal researchers working in Switzerland 
do not apply basic principles of study design to avoid bias and do not properly 
report their study outcomes. They also found that neither the Swiss regulatory 
authority nor the international journals and their peer reviewers had adequate 
knowledge to recognize these flaws.
In an attempt to improve the quality of research reports, several checklists 
and guidelines have been put in place, such as Consolidated Standards of Re-
porting Trials (consort) and Standards for Reporting of Diagnostic Accuracy 
(stard) for human clinical trials, Preferred Reporting Items for Systematic 
reviews and Meta-Analyses (prisma) for SRs and meta-analyses, and Gold 
Standard Publication Checklist (gspc), Animal Research: Reporting of In Vivo 
Experiments (arrive) guidelines for animal research (Glasziou et al., 2014; 
Hooijmans, Leenaars and Ritskes-Hoitinga, 2010) and HARRP, the harmonized 
animal research reporting principles, which are a recent attempt by ICLAS 
( International Council for Laboratory Animal Science) in harmonizing animal 
research reporting to further improvements in the scientific rigor of animal 
experiments (Osborne et al., 2018). The arrive guidelines (Kilkenny et al., 
2010) are the most widely known for reporting of animal-based experiments. 
These guidelines have recently been complemented by the Planning Research 
and Experimental Procedures on Animals: Recommendations for Excellence 
(prepare) guidelines, which help to ensure quality when preparing animal 
studies (Smith et al., 2017).
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The arrive guidelines were adopted by more than 1000 scientific journals, 
and more than 20 funding agencies were expected to endorse them in 2010 
(Baker et al., 2014; Enserink, 2017). Two years later, Baker et al. (2014) assessed 
the degree to which they had been endorsed by reviewing journals, such as 
Nature and PloS, and found that there was little improvement. The knowl-
edge about and the use of reporting guidelines, such as the arrive guide-
lines, is still not widespread, as a study by Reichlin, Vogt and Würbel (2016) 
has shown. Reichlin et al. asked animal experimenters in Switzerland to com-
plete a questionnaire regarding their use of measures against risk of bias. Only 
16% responded. The arrive guidelines were known by less than half (43.7%). 
Furthermore, Carbone and Austin (2016) found no increase in reporting of an-
algesic use in the articles published in journals that had agreed to endorse the 
arrive guidelines. Results of a recent randomized controlled trial of close to 
1,700 scientists, who submitted papers to the scientific journal PLoS One, sug-
gest that scientists are either ignoring the guidelines or are still unaware of 
their existence. Another finding was that, even when an ARRIVE checklist was 
completed, the correlating papers were actually not more compliant, which 
may indicate that researchers do not know what is expected of them and why 
providing this information is crucial, emphasizing the importance of proper 
training (Enserink, 2017; Hair et al., 2018).
5.1 Sources of Bias in Animal-based Research
There is a large number of potential sources of bias in animal research. Not sur-
prisingly, most published animal studies have some risk of bias (Macleod et al., 
2015). Safeguards to avoid bias in study design, conduct, and analysis include 
randomization of treatment groups to eliminate systematic differences be-
tween them, blinding of investigator to treatment and to handling of data, and 
reporting on sample size estimation (Macleod, 2011). Analytical errors may ac-
count for close to a quarter of the irreproducible studies (Freedman, Cockburn 
and Simcoe, 2015); thus, knowledge about statistical methods is essential. Oth-
er suggested items for reporting include: a clear description of the hypotheses 
tested or primary and secondary objectives of the study, housing and husband-
ry, including welfare-related assessments and interventions, adverse events, 
and interpretation of results, taking into account the hypotheses/study objec-
tives (Kilkenny et al., 2010). Part of the reproducibility and translatability crisis 
is considered to be due to poor experimental design and conduct of animal 
experiments (Bailoo, Reichlin and Würbel, 2014; Ioannidis, 2005; Macleod, 2011; 
van der Worp, 2010; Würbel, 2016), including the influences of inappropriate 
animal housing (Lahvis, 2017) and handling (Gouveia and Hurst, 2017), insuf-
ficient pain relief (Carbone and Austin, 2016; Herrmann and Flecknell, 2018a), 
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as well as the absence of other refinements, such as careful monitoring, early 
humane endpoints, and less inhumane killing methods to reduce pain, suffer-
ing, and distress (Herrmann and Flecknell, 2018b and 2018c). The other, and 
perhaps larger, part is due to insurmountable species differences (Pound and 
Bracken, 2014; Pound and Ritskes-Hoitinga, 2018), which Russell and Burch al-
ready discussed 60 years ago (1959, Chapter 5).
Another source of bias is selective reporting when publishing results of 
animal experiments (Briel et al., 2013; Ioannidis, 2012; Landis et al., 2012; Lees 
et al., 2012; Macleod et al., 2004; Pound and Bracken, 2014; Sena et al., 2010; 
Tsilidis et al., 2013; Würbel, 2016). One problem relates to negative findings—
studies for which the original hypotheses were not proven. Some of these are 
not published at all, which has long been recognized as a source of publication 
bias. The second problem relates to studies that are reported incompletely. For 
example, only the parts that demonstrate that the treatment is effective are 
reported, with whole experimental groups excluded from reporting. This is se-
lective outcome and analysis reporting bias (Ioannidis, 2012). These partially or 
unreported studies may be repeated by others and thus represent an unneces-
sary waste of animal lives. Incomplete reporting of published findings makes it 
impossible to replicate studies (Begley and Ellis, 2012). Because negative find-
ings are often not published (Scherer et al., 2018), the value of published find-
ings is over-estimated, which, in part, could explain some of the difficulties 
in translating promising preclinical results into effective therapies for human 
disease (Bath et al., 2009; Mergenthaler and Meisel, 2012; Sena et al., 2010).
Yet another pitfall is researchers’ freedom of flexibility in data collection, 
analysis, and reporting, which dramatically increases false-positive rates in the 
literature and, therefore, contributes to misleading animal research data and 
overestimation of its significance. Regardless of the nominal endorsement of a 
maximum false-positive rate of 5% (p ≤.05), standards for disclosing details of 
data collected and analyzed make false positive results very likely  (Simmons, 
Nelson and Simonsohn, 2011). The authors describe this as p-hacking. Often-
times, an experimenter is more likely to find evidence that an effect exists 
falsely than to find evidence that it does not correctly. This occurs because of 
the investigators’ degree of freedom with regard to the amount of data col-
lected and analyzed, the exclusion of certain observations made, the compari-
son or combination of conditions, the variables considered, and so forth. It 
is uncommon for researchers to make these decisions before undertaking ex-
periments. Their exploratory behavior is explained as ambiguity in how best 
to make these decisions and the desire to find statistically significant results.
Confirmatory bias is another potential pitfall, since people tend to in-
terpret ambiguous information in such a way that it supports a justifiable 
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conclusion that matches their own aspirations (e.g., Dawson, Gilovich and Re-
gan, 2002). HARKing (i.e., Hypothesizing After the Results are Known) (Kerr, 
1998) is another common and problematic practice in science. Statistical tests 
to differentiate true effects from random noise are designed for confirmatory 
research, not exploratory research. Thus, when researchers change their a prio-
ri hypotheses after obtaining their results, this leads to false conclusions.
An additional area that urgently needs refinement is transparency and data 
sharing to avoid publication bias and needless repetition of studies. Open-
ness is a cornerstone of science and could help in reducing the reproducibility 
problem science is facing (Errington et al., 2014; Harris, 2017; McNutt, 2014). It is 
essential to discover and correct errors. The Food and Drug Administration Mod-
ernization Act of 1997 (fdama) (Food and Drug Administration, 2018) requires 
scientists to register their hypotheses and endpoints in advance, if they plan to 
run a clinical trial on potential new pharmaceutical drugs (ClinicalTrials.gov). 
This new law went into effect in 2000. It also requires pharmaceutical compa-
nies to publish their results, thus, avoiding publication bias. Despite the insuf-
ficient enforcement of the law, as many scientists still do not report the results 
of their studies (Harris, 2017), the  indispensability of such provisions is demon-
strated by the findings of a study conducted by Kaplan and Irvin (2015). They 
assessed whether the fdama had any effect on study outcomes. Before the law 
was in place, 57% of drugs or supplements showed benefits; after the law was 
in place, 8% of the studies published confirmed their preregistered hypotheses 
(Kaplan and Irvin, 2015). Such a prospective registration process is currently ex-
ceptional for animal-based studies, but it is unquestionably required in order 
to enhance transparency, reduce selective reporting bias, and prevent duplica-
tion. The Center for Open Science, a nonprofit where researchers can register 
their hypotheses a priori (https://cos.io) and Preclinical Trials, a platform for 
registration at the outset of all types of animal studies (www.preclinicaltrials.
eu), will hopefully improve the current situation. An additional measure to im-
prove transparency, and potentially reproducibility, is data sharing, which is a 
requirement for publication by some major journals but many researchers still 
refuse to share. By sharing data, errors can be discovered (e.g., Salzberg et al., 
2001). This is especially important in animal research, since it helps reduce the 
number of animals used and sheds light on the real value of animal derived data.
5.2 Necessary Steps
The improved quality of human clinical trials was achieved by strategies to 
minimize bias, a priori power analysis and further biostatistics, clear defini-
tion of the primary and secondary endpoints, data monitoring and auditing, 
internationalization and inclusion of multiple centers, external steering com-
mittees and safety monitoring, rigid publication standards, trial registries, and 
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more (Dirnagl and Fisher, 2012). The lessons learned from the improvement 
of human clinical trial quality should be adopted by preclinical (Dirnagl and 
Fisher, 2012) and all other biomedical research fields (Hartung, 2013), where 
relevant and with appropriate changes, since flawed research is unscientific 
and unethical. The ethical issues with research involving animals become extra 
critical as needless animal suffering must be avoided, and as preclinical animal 
data generally forms the basis for decisions whether to proceed to human clin-
ical trials. Thus, in order to adhere to the 3Rs, the following efforts are crucial:
– Education and ongoing training of researchers in experimental design, sta-
tistical methods, and model selection (Justice and Dhillon, 2016).
– Close assistance in study design by institutional animal welfare bodies and
by biostatisticians.
– As a possible solution for the problem of false positives making their way
into the literature, some researchers suggest the p-value threshold should
be reduced to 0.005 (Chawla, 2017). Others say researchers should select and 
justify p-value thresholds for their experiments, before collecting any data.
These levels should be based on factors such as the potential impact of a
discovery. These thresholds could then be evaluated via registered reports, a
type of scientific article in which methods and proposed analyses are peer-
reviewed before any experiments are conducted (Chawla, 2017).
– Transparency must be improved as it is crucial to document all anticipated
or exploratory steps in the study. Prospective registration of all animal stud-
ies with their hypotheses and endpoints is essential to prevent selective-
reporting biases (Ioannidis, 2012) and avoid study duplications (Preclinical
Trials, n.d.).
– Disclosure and openness are critical elements of science for self- correction,
and they can help avoid poor practices, such as HARKing.
– The use of preparation and reporting guidelines, such as the prepare guide-
lines (Smith et al., 2017) combined with the arrive guidelines (Kilkenny
et al., 2010), should be a mandatory, legally required part of funding applica-
tions, project license applications, as well as publications. Education on how 
to fill out the checklists and present the required  information in the publica-
tion, as well as a focus on enforcement of  compliance to both by journals, is
critical (Eisen, Ganley and  MacCallum, 2014; Enserink, 2017; Hair et al., 2018;
Herrmann and Flecknell, 2018a).
– Raw data, analyses, and protocols must be made available to allow other
researchers to verify results. This can easily be achieved by using data re-
positories (e.g., https://datadryad.org or https://figshare.com).
– Reporting of all study outcomes to avoid traditional reporting bias and




– Retrospective assessments of animal studies (see Ec Expert Working Group
for Project Evaluation and Retrospective Assessment, 2013, pp. 28–32)
should be performed comprehensively and by independent experts; and all
results should be published to enhance transparency, minimize publication
bias, identify animal models lacking external validity, and, thus, improve fu-
ture research.
– Mandatory data sharing so that other scientists can build on the work and
discover errors faster (cf. the error in the Human Genome Project discov-
ered by Salzberg et al., 2001). Data sharing should be compulsory, especially
when research is publicly funded.
It is equally important that funding and regulatory bodies, animal ethics com-
mittees, animal welfare bodies, journal editors, and peer reviewers have a de-
tailed knowledge of these topics in order to recognize flawed research studies. 
This requires effective and thorough education and training of funders, animal 
ethics and welfare committees, and regulatory body members on how to assess 
animal research proposals (Vogt et al., 2016). Furthermore, in order to review 
these applications in-depth, enough time and manpower are a prerequisite.
6 Refinement: Are We Doing What We Can?
As presented in this chapter, knowledge about and implementation of refine-
ment of husbandry, experimental procedures and design, conduct, and report-
ing appears to still be patchy. Since adoption of refinement strategies has been 
inconsistent, it would seem that rather than use additional animals to carry 
out more refinement research, we should focus on the comprehensive applica-
tion of existing refinements in animal laboratories as well as on reducing and 
 replacing animals.
6.1 But What about the Refinement of Animal Models?
Animal models ought to describe a biological phenomenon that the model 
species has in common with the target species. Significance and validity, in 
terms of the translatability of results produced in an animal model to the hu-
man condition, “depend on the selection of a suitable animal model,” writes 
Hau (2008, p. 4), which is why comprehensive knowledge about comparative 
anatomy and physiology is essential. A majority of animal models developed 
with the expectation to study the origin, disposition, and treatment of hu-
man disorders and is created through experimental induction, genetic mod-
ification, or breeding of disease-causing mutations (Hau, 2008, p. 4). These 
presumed predictive models are used to find treatments or to assess the toxic-
ity of drugs and other chemicals (Hau, 2008). Hence, they cause conditions 
23Refinement on the Way Towards Replacement
<UN>
associated with pain and distress up to severe, long-lasting suffering for these 
animals. 
Some laboratory animal scientists focus on the refinement of animal mod-
els in an attempt to reduce  the suffering caused. Examples for refinement rec-
ommendations of animal models include those described for mice and rats 
who are utilized as models of ischemic stroke ( Percie du Sert et al., 2017), for 
rheumatoid arthritis (Hawkins et al., 2015), in experimental autoimmune en-
cephalomyelitis (eae) (Wolfensohn et al., 2013a), as models and in procedures 
involving seizures, convulsions, and epilepsy (Lidster et al., 2016; Wolfensohn 
et al., 2013b), and as models of sepsis and septic shock (Lilley et al., 2015). If 
the gathering of such recommendations does not involve additional harmful 
animal experiments, and in case these guidelines are then applied in practice, 
they could lead to an improvement of the individual animal’s life.
However, due to failure of numerous models to predict human outcomes 
(e.g., Joffe et al., 2016; Mak, Evaniew and Ghert, 2014; Pharmaceutical Research 
and Manufacturers of America, 2015, 2016), and due to limited funding, it 
seems crucial to first assess carefully which research methods and models to 
use. In the case of sepsis models, for example, there have been multiple pub-
lications highlighting the differences in human and mouse immunology (e.g., 
Mestas and Hughes, 2004; Rittirsch, Hoesel and Ward, 2007; Seok et al., 2013; 
Shay et al., 2013; Payne and Crooks, 2007). After over 20 years of unsuccessful 
research in this field, a number of scientists finally investigated why, out of 
the approximately 150 new compounds that were developed for the treatment 
of sepsis using mice, not one had beneficial effects for humans. They identi-
fied around 5,000 genes that are activated or deactivated by inflammation in 
humans who suffered from sepsis, trauma, or burns. They went on to look for 
the same genes in one commonly-used strain of mice and realized that there 
was no correlation (Seok et al., 2013). As a consequence of the dissimilarity 
of mouse and human immune systems, the entire field of sepsis research in 
mice has been called into question, regarding its predictive value for humans. 
Paradoxically, funding for this kind of animal research, which is also known for 
causing severe levels of animal suffering, is still ongoing (Leist and Hartung, 
2013). At the same time, human-based sepsis research has led to clinical trials 
of effective therapies (van der Poll, 2012).
7 Reduction and Replacement: Are We Doing What We Can?
Most animal research is being justified as indispensable to furthering human 
healthcare. However, despite measures being taken to improve the quality of 
animal-based research, the translational success rate from animal studies to 
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humans is low: Less than 12% of drugs entering clinical trials result in an ap-
proved medicine (Pharmaceutical Research and Manufacturers of America, 
2015, 2016); and between 51% and 89% of preclinical studies are not reproduc-
ible (Freedman, Cockburn and Simcoe, 2015; Harthorne and Schachner, 2012). 
There is an ongoing debate among scientists as to why animal models fail to be 
predictive: Is this mainly due to poor scientific rigor and reporting, to species 
differences, or to the fact that today we mainly deal with complex, oftentimes, 
chronic ailments of which many are not well understood and, thus, impossible 
to model in other animals?
As a consequence of the failure to translate findings to humans, new crite-
ria for mouse models have been described (Justice and Dhillon, 2016). Hop-
ing to enhance animal models of stroke, Dirnagl and Fisher (2012) call for 
international, multicenter, preclinical Phase iii-type studies of promising 
new ischemic stroke therapies in animals before moving to clinical trial. As 
Phase iii studies would be based on prior studies and would use various strains 
and species (Dirnagl and Fisher, 2012), as well as older animals with various co-
morbidities (e.g., diabetes mellitus, obesity, and hypertension) (Mergenthaler 
and Meisel, 2012), the severity of these experiments and the numbers of ani-
mals involved would markedly rise. Of close to 100 interventions that improved 
the outcome in animal stroke models, which were tested in clinical trials, only 
one intervention improved the outcome in human patients (O’Collins et al., 
2006). Despite decades of research, most translational stroke trials that aim 
to extrapolate basic research findings into clinical treatments, particularly in 
the area of neuroprotection, have failed (Mergenthaler and Meisel, 2012). The 
authors admit that, to date, there is no ideal animal model for stroke, and that 
more complex models are needed to improve translational success in experi-
mental stroke research (Mergenthaler and Meisel, 2012). Thus, at the time of 
writing, Mergenthaler and his colleague Stachelscheid are developing human 
stem cell-derived 2D and 3D models for stroke (vfa, 2017). Building on the lat-
est in vitro research to model human brain development and disease, they plan 
to employ a recently established protocol for generating 3D brain tissue, so-
called cerebral organoids, from human pluripotent stem cells that can be ap-
plied to study a number of human brain diseases (Lancaster and Knoblich, 
2014). Renner et al. (2017) further examined the development and potential 
differentiation of cerebral organoids, which hold great potential to advance 
human-relevant stroke research.
7.1 Potential for Reduction by Critical Appraisal of Animal Studies
Several unsuccessful animal models have been discussed, such as for Alzheim-
er disease (Cavanaugh, Pippin and Barnard, 2014; Pippin, Cavanaugh and 
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Pistollato, 2019, Chapter 20 in this Volume; Pistollato et al., 2016), for stroke 
(Shuaib et al., 2007; van der Worp et al., 2010), for tuberculosis (Fonseca et al., 
2017); for asthma (Mullane and Williams, 2014), for hiv/aids, for neurological, 
menopausal human therapy, and for cancer research as well as drug develop-
ment (Pippin, 2012). Since only disease models with high predictive validity are 
likely to yield positive results and treatments for humans, it is critical to assess 
the reliability, reproducibility, and validity of the animal model first. With the 
overall low quality and predictive validity of the majority of research studies, 
it has become evident that animal-based studies require rigorous evaluation 
(Pound et al., 2004). A solid methodological approach would be to systemati-
cally review and to perform meta-analyses of animal studies, as SRs are seen by 
experts in the field of evidence-based medicine as the highest level of medical 
evidence (Hooijmans, Leenaars and Ritskes-Hoitinga, 2010).
7.1.1 Systematic Reviews (SRs)
A systematic review (SR) is a literature review that focuses on a specific ques-
tion with the aim to identify and assess all relevant studies in order to generate 
new, high-quality evidence. Thus, it enables evidenced-based decision making 
(Norecopa, 2017). A SR may contain a meta-analysis. In a meta-analysis, the 
results of a number of independent studies are statistically combined to calcu-
late the average effect of studies addressing the same question, which may lead 
to more reliable conclusions and may help to minimize needless duplication 
of animal studies (Hooijmans et al., 2014a). SRs conform with the implementa-
tion of the 3Rs concept (Ritskes-Hoitinga, 2016), as their application leads to a 
more evidence-based choice of animal models (e.g., de Vries et al., 2012; Sloff 
et al., 2014; Zeeff et al., 2016). They help decrease unnecessary animal studies, 
the evidence they produce should further responsible animal use, and they 
increase scientific quality (van Luijk, 2016), as they are an excellent tool to 
 assess study quality by evaluating the internal, external, and construct validity 
of the models. Internal validity is the degree to which the design, conduct, and 
analysis of the experiment remove potential bias, so that the interpretation of 
a causal relationship between an experimental treatment and variation in an 
outcome measure is secured (Bailoo, Reichlin and Würbel, 2014). The extent to 
which animal data gives a basis for generalization to other animal and human 
populations, including other environmental circumstances, represents the ex-
ternal validity; and construct or predictive validity shows how good the model 
is, the rate to which the sampling properties are representative for the entities 
they ought to represent (Bailoo, Reichlin and Würbel, 2014; Würbel, 2017). An 
example for a SR on internal validity is the study of Macleod et al. (2008) and 
for construct validity, the work of Sena et al. (2010), both focusing on reasons 
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for translational failure of experimental stroke. SRs are a significant tool to 
identify quality issues with primary animal studies. For example, a recent SR 
on the welfare implications of toe clipping and ear notching revealed that the 
underlying animal experiments were too flawed to draw conclusions (Wever 
et al., 2017). SRs are excellent to assess the risk of bias in animal studies and 
thus to evaluate the reliability of the available evidence (van Luijk et al., 2014). 
Perel et al. (2007) systematically reviewed the success of treatments in  animals 
and in humans, with head injury, hemorrhage, thrombosis due to acute isch-
emic stroke, acute ischemic stroke, and osteoporosis as well as preventive 
medication in neonatal respiratory distress syndrome, with their applications 
in humans with these impairments. Their conclusion was that the incongruity 
 between animal and human studies may be due to bias or to the failure of the 
animal models to mimic clinical disease (Perel et al., 2007).
SRs of animal studies are still much less common than in the clinical setting, 
where they are frequently used to make evidence-based decisions on health-
care; but awareness of the benefits of the utility of SRs of animal research has 
been increasing (Hooijmans et al., 2014; van Luijk et al., 2014). The Collabora-
tive Approach to Meta-Analysis and Review of Animal Data from Experimen-
tal Studies (camarades) group, at the University of Edinburgh in the UK, 
and the Systematic Review Center for Laboratory Animal Experimentation 
(syrcle), at Radboud University Medical Center in the Netherlands, provide a 
supporting framework for groups who are or want to get involved in the SR and 
meta-analysis of data from experimental animal studies and offer advice and 
training (camarades, 2014; syrcle, n.d. b). syrcle has published a step-by-
step guide on how to identify all relevant animal studies (Norecopa, 2017), as 
well as a tool similar to the Cochrane tool for assessing risk of bias in random-
ized clinical trials (Higgins et al., 2011), to assess the risk of bias in animal-based 
studies (Hooijmans et al., 2014). It is important to receive proper training first, 
as one needs to be aware of the pitfalls and limitations of these tools, and how 
they can be misused and/or misleading (Gurevitch et al., 2018). Various types 
of reporting biases, together with the limited methodological quality of some 
studies on which meta-analyses and SRs are based, can impede their conduct 
and interpretation (e.g., Benatar, 2007). When publication bias against nega-
tive animal studies exists, it will lead to an overestimate of the value of animal 
studies. It is likely that if unpublished studies were to be included, then SRs 
would show more studies with no effect in animals (Akhtar, Pippin and San-
dusky, 2009). Checklists and tools have been proposed to help improve SRs and 
meta-analyses (Hooijmans et al., 2014; Moher et al., 2009).
The use of SRs should be standard practice within animal-based research, 
in the same way it has become a vital part of clinical research (Hooijmans, 
Leenaars and Ritskes-Hoitinga, 2010; Hooijmans and Ritskes-Hoitinga, 2013; 
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Pound and Bracken, 2014; Pound et al., 2004; Sandercock and Roberts, 2002). 
SRs should be conducted prior to a new animal study to assess the valid-
ity of the proposed animal model and to avoid needless animal use (Ritskes- 
Hoitinga and Wever, 2018). For example, in refinement research, SRs are an 
efficient way to gather new high-quality data without having to experiment 
on additional animals. As shown in this chapter, the implementation of new 
knowledge about refinements to improve animal welfare has proven very 
difficult. A prominent example is the use of carbon dioxide to kill animals. 
Extensive research conducted on this welfare topic has produced overwhelm-
ing evidence against its use, but these findings still have not led to the abol-
ishment of this common practice. At the time of writing, Turner et al. are 
conducting a SR on the use of carbon dioxide as a killing method for mice and 
rats. Their protocol (syrcle, n.d. c), as well as the protocols of others, are pub-
lished on the syrcle website and, since 2018, protocols of SRs relevant to 
human health can be registered at the international prospective register of 
SRs, called prospero (https://www.crd.york.ac.uk/prospero/).
7.1.2 Other Retrospective Assessments
Conducting retrospective assessments (RAs) is a useful way to identify dis-
ease models and research methods that may be of limited value. Since 2013, 
RAs are mandatory for certain animal studies in the European Union (Euro-
pean Parliament, 2010, Article 39). Members of the animal research inspector-
ates have been required to assess the outcomes of animal studies that were 
classified as severe and/or use non-human primates. The animal researcher 
has to submit the necessary documents so that the competent authority 
can evaluate whether the study objectives were met, the actual harm inflict-
ed, and whether the severity of procedures coincided with the  prospective 
assessments, and the number of animals used. In  addition, the competent au-
thorities must appraise any component that can advance the implementation 
of the 3Rs (European Parliament, 2010, Article 39).
These RAs could be extremely effective in facilitating a critical review of the 
use of animals in scientific procedures, if there are sufficient and qualified per-
sonnel to conduct them, as the EC’s aim with these RAs is to identify 3Rs im-
provements and enhance transparency to the public (EC Expert Working Group 
for Project Evaluation and Retrospective Assessment, 2013). Publication of RA 
results of all studies, including those that produced negative results and may 
not be published elsewhere, would likely be of significant value. It would in-
crease the knowledge base in a range of disciplines, reduce risks of duplication 
of studies, and inform the design of future research (EC Expert Working Group 
for Project Evaluation and Retrospective Assessment, 2013). However, only 
about one sixth of all EU Member States agreed to make the RA results publicly 
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available. This is not enough to meet the EC’s goals. To achieve maximum ben-
efit, access to study results should be given not only to regulatory authorities but 
to independent experts, in order for them to perform critical reviews of these 
data. And all RA results have to be made publicly available. It is possible to do 
so and still protect intellectual property by redacting and anonymizing certain 
parts of the documentation.
7.1.3 Necessary Steps
As outlined earlier, the scientific and ethical justification for animal models 
of human diseases depends on their providing an opportunity to investigate 
disease biology and to determine potentially beneficial therapies for humans 
(Benatar, 2007). Thus, only after an animal model has proven to have satisfac-
tory predictive value for humans, should it be refined as much as possible to re-
duce pain, suffering, distress, and lasting harm. If proven of no value, it should 
be abandoned. Such models should no longer receive regulatory approval nor 
funding, nor should they be accepted by scientific journals. SRs and meta- 
analyses of animal models as well as RAs of all animal experiments performed by 
independent experts would benefit animals and human patients, as they help 
to identify flawed studies and to eliminate misleading, invalid models, and ex-
perimental designs. Such a rigid quality control of animal-based research would 
most certainly lead to a significant reduction of animal use and, thus, to an in-
creased effort to find more animal-free, robust, human biology-based models.
7.2 Is the Biomedical Research Industry Shifting away from Animal  
Use?
The problem is that it hasn’t worked, and it’s time we stopped dancing 
around the problem. […] We need to refocus and adapt new methodolo-
gies for use in humans to understand disease biology in humans.
zerhouni, former head of the US National Institutes of Health, quoted in  
McManus, 2013
There is growing recognition that instead of focusing efforts on trying to re-
fine animal experiments, a primary focus on human-relevant data is needed 
(Collins, 2011; Giri and Bader, 2015; Langley et al., 2015, 2017; Zerhouni, 2014), 
as a significant challenge that medical research is facing today is the un-
derstanding and possible treatment of chronic, complex diseases of which 
many are not well understood and, thus, cannot be modeled in other animals 
(Tsukamoto, 2016). Tsukamoto asks in a Drug Discovery Today editorial: “How 
can we replicate human diseases that develop later in life and/or result from 
a prolonged unhealthy lifestyle, far beyond the lifespan of rodent animals? 
What makes us expect that the outcomes from carefully controlled animal 
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 experiments can be duplicated in patients with substantial heterogeneity 
across various aspects (age, gender, genetics, lifestyle, disease stage, etc.)?” 
Transgenic mice commonly used as disease models, oftentimes contain mul-
tiple copies of presumed  disease-causing transgenes, and it is dubious “wheth-
er phenotypes seen in mice as a result of this ‘genetic exaggeration’ have any 
relevance to the corresponding human diseases” (Tsukamoto, 2016). Zerhouni 
(2014) calls for a new approach that redirects the drug-development paradigm 
that commences with the patient to explore the genetic foundation of molecu-
lar changes inherent to human pathophysiology.
As Russell and Burch remarked in 1959, “refinement is never enough, and 
we should always seek further for reduction and if possible replacement” 
(Chapter 4). Since 1959, we have gathered immense knowledge about animals 
and their consciousness, which has led to the public acknowledgment by a 
group of prominent neuroscientists that other animals are conscious too: The 
Cambridge Declaration on Consciousness (Low, 2012). Since 1959, the tech-
nology revolution has also immensely changed the field of life sciences and, 
hence, provides us with the tools to move away from using animals (Langley 
et al., 2015, 2017).
Current legislation, reflecting societal concerns, as well as the scientific fail-
ures of animal research should function to drive research, testing, and educa-
tion away from using live animals. Some areas of education and training are 
already using animal-free teaching approaches, for ethical reasons and educa-
tional advances (see e.g., Bones et al., 2019, Chapter 23; Pawlowski et al., 2019, 
Chapter 22 in this Volume). In the area of chemical-toxicity testing, some prog-
ress has already been made in finding advanced non-animal methods, initiated, 
for example, through the pioneering Toxicology in the 21st Century (Tox21), a US 
federal initiative (National Research Council, 2007; National Toxicity Program, 
2004; Rovida et al., 2015; Zurlo, 2012). However, the general tendency in toxicol-
ogy is to introduce new methods without eradicating all the old (animal-based) 
ones (Rovida et al., 2015). Still, the acceptance of animal-free alternatives by 
regulators without additional animal-based tests, in the pharmaceutical and 
food-toxicity testing fields, should be possible when proven scientifically qual-
ified for the specific context of use. However, awareness and acceptance of 
scientically-valid, non-animal methods is still low among regulators as well as 
research workers (Ramirez et al., 2015).
The high failure rate of drugs in the clinical phase (Begley and Ellis, 2012; 
Food and Drug Administration, 2004; Hutchinson and Kirk, 2011; Kola and 
Landis, 2004; Olson et al., 2000) indicates not only poor scientific quality and 
cognitive bias but also that animals are not good models for humans (e.g., 
Greek and Kramer, 2019, Chapter 17 in this Volume; Kramer and Greek, 2018; 
Knight, 2019, Chapter 14 in this Volume; Leist and Hartung, 2013); and the same 
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applies to food-safety testing in animals (Rovida et al., 2015). Already back in 
2000, an eye-opening report (Olson et al., 2000) was published about the re-
sults of a multinational pharmaceutical company survey, which served to bet-
ter understand the concordance of the toxicity of pharmaceuticals in humans 
compared with other animals. The weakness of animal studies to predict the 
human toxicity of drugs became apparent, as results revealed a human toxicity 
concordance rate of 71% when tested in multiple rodent as well as non-rodent 
species. When they compared humans with rodent species only, there was a 
43% correlation; humans compared with non-rodent species showed a 63% 
match. Drug toxicity studies in animals are long-lasting and, hence, may cause 
severe suffering; and they are frequently not predictive for effects in humans 
(Hartung, 2009).
Cumulative knowledge is essential for scientific progress. Thus, there is 
increasing awareness of the importance of data sharing and collaboration to 
shift the paradigm away from using unsound animal models for drug toxicity 
testing. The human toxome project, a systematic mapping of the entirety of 
toxicity pathways, is ongoing in the area of chemical risk assessment. Rovida 
et al. (2015) suggested that this project should be extended to include the as-
sessment of efficacy and adverse effects of drugs and food ingredients. Con-
tinued reliance on animal models appears implausible to enhance the cur-
rent poor rate of clinical approval of new treatments. This is why Humane 
Society International initiated the Biomedical Research for the 21st Century 
(BioMed21) Collaboration. The BioMed21 Collaboration is working inter-
nationally with health experts, regulatory and research agencies, funding 
bodies, and others to develop innovative research roadmaps that  focus on 
understanding human disease pathophysiology. The goal is to further this human- 
focused approach to studying, preventing, and treating disease (BioMed 
21 Collaboration, n.d.). A central recommendation of the BioMed21 2015 
 workshop was to use the Adverse Outcome Pathway (aop) concept in bio-
medical research. aop, an important concept in toxicology, describes a logical 
sequence of causally-linked biological events that lead from the first action of a 
 compound to an eventual adverse effect on human health (Langley et al., 2017). 
Furthermore, it was recommended that technological advances should be com-
bined in human-specific tools and models. The importance of funding these 
new approaches was highlighted as well as the need for faster validation and 
acceptance by the scientific community, funding bodies, and scientific jour-
nals, who mostly still postulate the use of animals (Langley et al., 2015, 2017).
BioMed21 is a rare example for a non-animal-based approach in the area of 
applied research, which—together with the field of basic research—uses the 
majority of animals. Overall, there is little evidence that these fields are reduc-
ing the use of animals, as the 3Rs posit we must. Quite the contrary: Animal use 
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has been increasing in the new century (Taylor and Rego, 2016), mainly due to 
an increasing generation and use of genetically altered animals (Bailey, 2019, 
Chapter 19 in this Volume; Carbone, 2004; Ormandy, Schuppli and Weary, 2009; 
Ram, 2019, Chapter 15 in this Volume), which has, in recent years, been fueled 
by excitement over new technologies, such as crispr, an easier genetic modi-
fication technique that will most probably lead to a further steep increase in 
animal numbers and species modified (Bailey, 2019). These new technologies, 
however, have not kept their promise of improving translation between animal 
models and human health, as they have failed to increase the efficiacy and the 
safety of drugs (Hunter, 2011). For a detailed discussuion on the scientific and 
ethical issues of the genetic modification of animals, see Chapter 19 in this 
Volume (Bailey, 2019).
7.2.1 Funding
Progress in the development of replacement methods seems to be limited 
most by the availability of funds. Some governments and non-governmental or-
ganizations around the world are providing scarce funding, especially when 
compared to funds available for biomedical and life research as a whole. It is 
unclear how much of the annual worldwide funds—an estimated US$100 bil-
lion for biomedical research alone (Chalmers and Glasziou, 2009) and up to 
US$240 billion for all the life sciences (Røttingen et al., 2013)—are currently 
used for research centered around the use of animals, as it is not differentiated 
in the statistics (e.g., in Germany, bmbf, 2017). Daneshian (2016) estimated 
that in 2015, funds for projects with animals in Germany, including animal re-
search facilities, were about €1920 million; funds for replacement methods 
ranged around €6.45 million. These financial means, mainly derived from Ger-
man taxes, are distributed in opposition to Germany’s declared political goal of 
working towards replacement of animal use at the national level (bmel, 2015) 
as well as the EU level (European Parliament, 2010, Recital 10).
In preclinical human model development, the Tissue Chips for Disease Mod-
eling and Efficacy Testing initiative, funded by US National Center for  Advancing 
Translational Sciences (ncats) of the National Institutes for Health (nih), is 
a rare example. Its goal is to explore human microphysiological systems as po-
tential facilitators of drug development in numerous disease areas. Its bud-
get is approximately US$15 million, annually, for 13 two-year projects (ncats, 
2017); while nih, being the biggest funder and research organization in the 
world, has annual funds of about US$39 billion for medical research alone 
(nih, 2019). The EU framework program for research and innovation, Hori-
zon 2020 (European Commission, n.d.), has, at the time of writing, supported 
16 research projects devoted to alternative methods to animal testing, with a 
total of €90 million (European Parliament, 2017). The main research activities 
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are targeted towards developing complex in silico and in vitro human-based 
systems for better and more cost-effective safety and efficacy testing of chemi-
cals, nanoparticles, vaccines, and drugs (European Parliament, 2017).
Between 1981 and 2015, the German Federal Ministry for Education and Re-
search (Bundesministerium für Bildung und Forschung, bmbf) gave €160 mil-
lion in funding for over 500 3Rs research projects. Aside from not exclusively 
funding replacement projects, the funds dedicated to the 3Rs were sparse; for 
example, in the 6-year period between 2010 and 2015, less than €20 million 
were available (bmbf, 2016). The UK National Centre of the Replacement, Re-
finement and Reduction of Animals in Research (NC3Rs) is the largest funder 
of such research in the United Kingdom (Burden et al., 2015). Between 2004 and 
2014, NC3Rs awarded 200 grants worth approximately US$54 million (Burden 
et al., 2015); the annual overall budget of NC3Rs is approximately €11.2 million 
(NC3Rs, n.d. d). In contrast, the German national 3Rs center, Zentrum zum 
Schutz der Versuchstiere (Bf3R), has an annual budget of €1.5 million to run all 
of its operations (Bundesinstitut für Risikobewertung, 2016) and provides ap-
proximately €350,000 to external replacement and refinement research groups 
per year (Bundesinstitut für Risikobewertung, 2018). Replacement research 
has to compete with refinement research for these limited funds (bmbf, 2016; 
NC3Rs, n.d. a).
A donor that exclusively provides money for the first R is the cosmetic com-
pany Lush, which in 2012 established the Lush Prize in collaboration with the 
UK not-for-profit group, Ethical Consumer Research Association (Redmond, 
2019, Chapter 27 in this Volume). Lush provides £250,000 in funding each year 
for the main prize categories, with additional funds for regional awards in Asia 
and the Americas (Lush Prize, n.d.). An example for a charity providing some 
funding is People for the Ethical Treatment of Animals (peta) International Sci-
ence Consortium (pisc), which, in June 2017, awarded funding to develop four 
in vitro exposure systems to researchers from institutions in the United King-
dom, United States, and Belgium that are leaders in the development of non-
animal methods to test the toxicity of airborne substances (peta  International 
Science Consortium, n.d. a). pisc assists with funding where promising in vi-
tro or in silico techniques require further development or validation in order 
to gain regulatory acceptance. pisc focuses on toxicology and until, 2017, it 
has contributed about €2.9 million towards improving and implementing 
non-animal research methods (peta International Science Consortium, n.d. 
b). The Alternatives Research & Development Foundation (ardf) funds and 
promotes the development and validation of non-animal methods in biomedi-
cal research, product testing, and education and has provided US$3.25 million 
in funds since 1993 (Alternatives Research & Development Foundation, 2018). 
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The US National Anti-Vivisection Society (navs) provides some grants through 
the International Foundation for Ethical Research (ifer) for early career sci-
entists to develop humane, human-relevant alternatives that replace animal 
use (navs, 2018). Overall, there are a few local and international initiatives and 
prizes but most focus on animal testing, while non-animal approaches in basic 
and applied research lag behind. Moreover, to ensure the field of animal-free, 
human-based research methods and approaches is continually and substan-
tially growing, increased, stable governmental funding must be provided.
7.2.2 Education and Training
Another obstacle in shifting the current research paradigm is the limited avail-
ability of educational and training courses on animal-free methods and ap-
proaches in all areas of biomedical science, but especially in basic and applied 
research, since current available guidance documents and databases as well as 
courses almost exclusively focus on testing alternatives. There are some efforts 
being made to improve experimental design, conduct, and reporting; for ex-
ample, online resources are available at some of the national 3Rs centers, such 
as at Norecopa, Norway’s National Consensus Platform for the advancement of 
the 3Rs (Norecopa, 2016b) and the UK NC3Rs (NC3Rs, n.d. b, c), since quality 
issues of biomedical research has become apparent.
By EU law, the researcher must be well informed about state-of-the-art 
developments in the field of investigation, and animals must only be used if 
all possible alternatives are considered to be inadequate (EC Joint Research 
Centre, 2013). The EC Joint Research Centre’s EU Reference Laboratory for 
 Alternatives to Animal Testing – European Centre for the Validation of Alter-
native Methods (eurl ecvam) Search Guide (EC Joint Research Centre, 2013) 
and Data Base Service on Alternative Methods to animal experimentation 
(DB-alm) (EC Joint Research Centre, 2017) ought to assist with the search for 
alternatives to animal use. However, even for experts in the respective field, 
it is a lengthy and difficult task, as existing search systems do not support the 
necessary search strategies.
Altertox Academy, formerly caat Academy, offers hands-on training, but 
primarily for toxicologists, in human-relevant alternative methods and tech-
nologies (Altertox Academy, 2018). Education and training courses, mandatory 
for all animal researchers in the EU, include one animal-free methods module 
(e.g., felasa B courses), but of a 40 hour felasa B course, about one hour is 
dedicated to replacements, and generally only alternatives used in toxicology 
testing are covered (e.g., Berliner Kompaktkurse, 2017, p. 23). In 2016,  the Uni-
versity of California (UC) San Diego offered a course that introduces partici-
pants to the available non-animal research methods, their efficacy, and how to 
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identify and implement them. It covered more areas than just regulatory toxi-
cology (UC San Diego, 2018). However, detailed courses with extensive mod-
ules for all areas of the biomedical sciences currently do not exist.
7.2.3 Search Engine for Alternative Methods
What is urgently needed—aside from specific education and training 
courses—is an unbiased, freely available search engine that is able to find 
correlations regarding scientific purpose between animal experiments and 
 alternative methods and, at the same time, 3Rs-relevant deviances in the 
methodologies (in vitro versus in vivo). Scientists from the Leibniz Institute 
for Social Sciences (gesis) and the German Federal Institute for Risk Assess-
ment (Bundesinstitut für Risikobewertung, BfR) have laid the foundation for 
such a search engine, using machine learning. The project is called smafira, 
which stands for “smart feature-based interactive ranking algorithm.” The goal 
of smafira is to develop automated but mechanistically transparent search 
procedures that focus on such deviations  and, thus, to provide an improved 
automatic support to search for non-animal methods (fisaonline, n.d.). This 
search engine will drastically reduce the number of documents scientists have 
to go through (gesis, n.d.). A first version of the smafira search engine is 
anticipated to be available in the second half of 2019 (Daniel Butzke, BfR, per-
sonal communication, January 2019).
8 Ways to Work Towards Replacement
Directive 2010/63/EU, a progressive animal protection legislation in the field, 
sums up some important steps that have to be taken to work towards a para-
digm shift, when it states (emphasis added): “The availability of alternative 
methods is highly dependent on the progress of the research into the devel-
opment of alternatives. […] the Commission and the Member States should 
contribute through research and by other means to the development and 
validation of alternative approaches.” (Recital 46). Article 47 declares: “The 
Commission and the Member States shall contribute to the  development 
and validation of alternative approaches which could provide the same or 
higher levels of information as those obtained in procedures using animals 
[…], and they shall take such other steps as they consider appropriate to en-
courage research in this field. […] Member States should, at national level, 
ensure the promotion of alternative approaches and the dissemination of 
information […]”.
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8.1 Political Engagement
The needed political engagement that Directive 2010/63/EU demands from its 
Member States to move towards an animal-free world of scientific experimen-
tation was made a priority by the Dutch government in 2016. The Netherlands 
National Committee for the protection of animals used for scientific purposes 
(NCad) has developed a vision and plan of action for moving away from labo-
ratory animal use. The Dutch goal is to phase out the utilization of animals in 
a number of fields by 2025, namely in regulatory testing of chemicals, food in-
gredients, pesticides and (veterinary) medicines, and biological products, such 
as vaccines (NCad, n.d.). The Committee also plans to steadily reduce animal 
involvement in regulatory preclinical research and basic research: “If we are to 
make the transition to non-animal research methods, we must make a para-
digm shift away from existing mindsets and practices” (NCad, n.d., p. 3), a task 
which seems to be impossible without political involvement. The Dutch strat-
egy holds the potential to act as a driver for other countries to follow this path.
8.2 Legislative Change
There is a need for regulators who are brave to move legislative change for-
ward. The reason for the continued use of animals for regulatory testing is 
legislative, as existing policies require that new drug candidates are tested on 
animals before they can be assessed in human clinical trials, regardless of the 
fact that these animal tests are often unreliable in assessing safety and efficacy 
in humans (Greek and Kramer, 2019, Chapter 17 in this Voume). These regula-
tions need to be amended according to scientific knowledge, and serious ef-
forts need to be made to accelerate the development of advanced, humane, 
and human-relevant models (Archibald, Coleman and Drake, 2019, Chapter 18 
in this Volume).
8.3 Redeployment of Funds
Absolutely essential for the paradigm change towards advanced, animal-free 
science and better healthcare is the redirection of funding. The limited fund-
ing for replacement research, oftentimes, has to compete with refinement 
 research (e.g., bmbf, 2016; NC3Rs, n.d. a). These scarce funds should be used 
to further human biology-based approaches. Also, regarding taxpayers’ money, 
the national governments, arguably, have the responsibility to use the funds in 
the name of a society that has repeatedly voiced that more needs to be done 
to replace animals in science. Moreover, our society is ethically evolving, with 
evidence of dwindling acceptance for animal suffering in the name of sci-
ence. And it is being increasingly acknowledged that the continued reliance 
on  animal models is unlikely to improve significantly the currently poor rate of 
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clinical approval of new treatments. Thus, animal-based research also contrib-
utes to resources being wasted (Harris, 2017; Ioannidis et al., 2014; Keen, 2019, 
Chapter 10 in this Volume).
Aside from redeploying funds, partially to preclinical human-relevant dis-
ease research (Langley et al., 2017) and to clinical rather than basic research 
(Pound and Bracken, 2014), a large part of funding should be dedicated to dis-
ease prevention efforts. To combat the increasing prevalence of dementia, for 
example, human-focused, non-animal models and methods, such as compu-
tational methods, advanced brain imaging techniques, and epidemiological 
studies should be given funding preference (Pistollato et al., 2016). Another 
extremely important area of disease prevention is basic public healthcare 
(Marks, 2012) as well as nutrition and lifestyle education. In addition, funds 
should also be used for pollution control, as pollution is currently found to be 
the largest environmental cause of disease and premature death around the 
world (Landrigan et al., 2017). The World Health Organization (who) estimat-
ed that around 3 million people die prematurely every year due to air pollution 
alone (Watts et al., 2017). In 2015, diseases caused by pollution were responsible 
for about 16% (9 Mio.) of all human deaths worldwide, which is three times 
more than deaths from tuberculosis, malaria, and aids combined and 15 times 
more than all wars and other means of violence together (Landrigan et al., 
2017).
8.4 Education and Training
Education as well as re- and ongoing training about how to conduct state-of-
the-art science and report it properly, as well as education on research ethics 
and bioethics are crucial. They enable students and scientists to gain a solid 
grounding in science based on non-animal models, while sincerely embrac-
ing the hierarchy of the 3Rs. Such learning objectives should be made avail-
able and should be mandatory for everyone planning to work or working in 
biomedical science. Education and retraining are the most important means 
to move away from the current thought culture and practice of animal use to-
wards a new, humane research paradigm.
8.5 Scientific Collaboration
As Russell and Burch observed in 1959, “As we shall see, replacement is widely 
used in some fields, while in others it is very far from being exploited to the 
full, if at all. Moreover, such developments have been largely empirical, and 
largely independent of each other” (Chapter 5). At the moment, 3Rs experts 
are  divided into replacement experts, on the one hand, and refinement ex-
perts, on the other. Animal welfare bodies and national committees in the 
EU (Directive 2010/63/EU, Recital 48), for example, are supposed to advise 
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 scientists about the application of the 3Rs but seem to have little to no knowl-
edge about available replacements and novel animal-free approaches to sci-
entific questions (van Luijk et al., 2012; van Luijk et al., 2013). To achieve the 
ultimate goal in shifting the focus from refinement of animal use to replace-
ment of animal use the animal research community needs to engage with re-
placement experts. National 3Rs centers should be equipped with a majority of 
experts in replacement methods, and a close collaboration between replace-
ment experts and animal researchers appears crucial in moving towards ani-
mal replacement. To accelerate the development of new human biology-based 
approaches, a multidisciplinary approach is essential for bringing together the 
newest technologies and experts from various disciplines (Langely et al., 2017; 
Noor, 2019,  Chapter 25 in this Volume).
9 Final Remarks
Looking into the future of animal-based science, Carbone (2004) wrote that 
morality and politics will continue to be the drivers for replacement research. 
Since the introduction of the principles, it has been widely held that animal re-
searchers have an ethical responsibility to minimize any pain, distress, fear, suf-
fering, and harm caused to animals when keeping them confined and utilizing 
them for invasive experiments without their consent. To apply the knowledge 
gained through animal welfare and refinement research is good veterinary and 
scientific practice, but it is not a substitute for reduction and replacement of 
animal experimentation. Indeed, Balls warned “that refinement can be used 
as a convenient way of showing commitment to the 3Rs, while ensuring that 
animal experimentation is seen as respectable and can be allowed to continue, 
while the fundamental ethical questions raised by it are avoided” (2010, p. 21). 
Thus, we have to be on guard that refinement is not used as a whitewashing 
tool, but its full application, which is an ethical imperative, must be guaran-
teed during the transition to human-relevant, animal-free methodologies.
Aside from extensive flaws in the way the majority of animals are housed 
and treated, and the poor conduct and reporting of many animal studies, the 
general lack of transparency around the use of animals in research as well as 
the low rate of critical appraisal of animal experiments are apparent. These 
failings have led to incorrect data and an overestimation of their  significance 
(Cohen, 2018). Unnecessary harm inflicted upon these animals and, in the case 
of medical research, the harms done to patients who suffer from adverse re-
actions to drugs that were tested safe in animals or who are  urgently waiting 
for treatments are serious issues that need to be addressed. A commitment to 
adhere to the 3Rs and to good scientific practice as well as to address societal 
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concerns about the use of animals in science would require a strong shift away 
from animals towards the use of human-relevant approaches.
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